Skip to search formSkip to main contentSkip to account menu

100 ML eptifibatide 0.75 MG/ML Injection [Integrilin]

Known as: INTEGRILIN 75 MG in 100 ML Injection, 100 ML Integrilin 0.75 MG/ML Injection, Eptifibatide 0.75 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Integrilin] 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (1)

100 ML eptifibatide 0.75 MG/ML Injection
InjectionIntegrilinSodium Hydroxidecitric acid monohydrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
EPTIFIBATIDE-LOADED LIPOSOMES MICROFLUIDIC-BASED LOADING AND SET-UP OF AN HPLC ANALYSIS
BACKGROUND Eptifibatide (Integrilin®) is an intravenous peptide drug that selectively inhibits ligand binding to the platelet… 
2013
2013
Bringing pharmacogenetics to the bedside
Dear Editor, The study ‘Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease… 
2003
2003
Évaluation de l‘utilisation d‘un inhibiteur de la glycoprotéine IIbIIIa, l‘Integrilin ® , dans un service de cardiologie
Les inhibiteurs de la glycoproteine IIbIIIa, en bloquant directement la voie finale commune de l‘agregation plaquettaire… 
2000
2000
Inhibiteurs des glycoprotéines plaquettaires IIb-IIIa : utilisation clinique et effets physiopathologiques associés
Le complexe GPIIb-IIIa (integrine alphaIIbbeta3) constitue une nouvelle cible pour les medicaments antithrombotiques. En bloquant… 
1999
1999
Eptifibátida INTEGRILIN (SP Europa)